Tempus AI Inc

TEMNASDAQ · USD
69.97USD0.00 (+1.63%)
255

Tempus AI Inc (TEM) Implied Volatility Current

TEM implied volatility is 77%. IV Rank is 60%, placing current premiums in the middle of their 52-week range.

Read more

Tracking TEM implied volatility helps you identify when options premiums on Tempus AI Inc are historically cheap or expensive, and where the best trades are hiding. Tempus AI Inc implied volatility reflects the market's expectation of future price movement: when TEM IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Tempus AI Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TEM, tracking metrics like TEM IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TEM signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies.

In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TEM implied volatility sits today versus where it has been. Our scanner ranks Tempus AI Inc implied volatility against its historical range, surfaces extremes in TEM IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Tempus AI Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
59.52%IV Rank
Moderate

IV is slightly elevated - premiums are richer, leaning toward sellers.

Implied Volatility (30d)77.38%

IV Rank59.52%

Historical Volatility (30d)101.76%

IV - HV-24.38%

As of September 16, 2026

Trade options with IV on your side

Track TEM IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial